• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

再生障碍性贫血导致替莫唑胺治疗的多形性胶质母细胞瘤患者死亡。

Aplastic anemia as a cause of death in a patient with glioblastoma multiforme treated with temozolomide.

机构信息

Department of Clinical Oncology and Radiotherapy, Charles University Hospital and Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.

出版信息

Strahlenther Onkol. 2010 Aug;186(8):452-7. doi: 10.1007/s00066-010-2132-3. Epub 2010 Jul 29.

DOI:10.1007/s00066-010-2132-3
PMID:20803286
Abstract

BACKGROUND

Standard treatment of glioblastoma multiforme consists of postoperative radiochemotherapy with temozolomide, followed by a 6-month chemotherapy. Serious hematologic complications are rarely reported.

CASE REPORT AND RESULTS

The authors present the case of a 61-year-old female patient with glioblastoma multiforme treated with external-beam radiation therapy and concomitant temozolomide. After completion of treatment, the patient developed symptoms of serious aplastic anemia that eventually led to death due to prolonged neutro- and thrombocytopenia followed by infectious complications.

CONCLUSION

Lethal complications following temozolomide are, per se, extremely rare, however, a total of four other cases of aplastic anemia have been reported in the literature so far.

摘要

背景

多形性胶质母细胞瘤的标准治疗包括术后替莫唑胺放化疗,随后进行 6 个月的化疗。严重的血液学并发症很少见。

病例报告及结果

作者报告了一例多形性胶质母细胞瘤患者的病例,该患者接受了外照射放疗和替莫唑胺联合治疗。治疗完成后,患者出现严重再生障碍性贫血症状,最终因中性粒细胞和血小板减少持续时间延长并继发感染并发症而死亡。

结论

替莫唑胺治疗后的致死性并发症本身极为罕见,但迄今为止,文献中总共报告了其他 4 例再生障碍性贫血病例。

相似文献

1
Aplastic anemia as a cause of death in a patient with glioblastoma multiforme treated with temozolomide.再生障碍性贫血导致替莫唑胺治疗的多形性胶质母细胞瘤患者死亡。
Strahlenther Onkol. 2010 Aug;186(8):452-7. doi: 10.1007/s00066-010-2132-3. Epub 2010 Jul 29.
2
Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with Temozolomide.多形性胶质母细胞瘤患者接受替莫唑胺治疗时出现的意外再生障碍性贫血病例。
J Neurooncol. 2007 Oct;85(1):105-7. doi: 10.1007/s11060-007-9398-z. Epub 2007 May 16.
3
Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study.替莫唑胺联合放疗作为多形性胶质母细胞瘤术后的治疗方法。I/II期研究。
Strahlenther Onkol. 2005 Jun;181(6):372-7. doi: 10.1007/s00066-005-1359-x.
4
A rare case of aplastic anemia caused by temozolomide.一例由替莫唑胺引起的罕见再生障碍性贫血病例。
South Med J. 2009 Sep;102(9):974-6. doi: 10.1097/SMJ.0b013e3181b1d2fa.
5
Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.替莫唑胺在新诊断多形性胶质母细胞瘤放化疗联合治疗中的应用:II期临床试验
Anticancer Res. 2003 Nov-Dec;23(6D):5159-64.
6
[Temozolomide in patients with a glioblastoma multiforme: new developments].[替莫唑胺治疗多形性胶质母细胞瘤患者:新进展]
Ned Tijdschr Geneeskd. 2005 Jun 18;149(25):1376-8.
7
Chemopotentiation by ultrafractionated radiotherapy in glioblastoma resistant to conventional therapy.超分割放疗对常规治疗耐药的胶质母细胞瘤的化疗增敏作用。
Tumori. 2010 Sep-Oct;96(5):771-5. doi: 10.1177/030089161009600522.
8
Temozolomide in glioblastoma multiforme of the elderly.替莫唑胺用于老年多形性胶质母细胞瘤的治疗
Tumori. 2002 Jan-Feb;88(1 Suppl 1):S69-70. doi: 10.1177/030089160208800120.
9
First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience.卡莫司汀植入物一线治疗恶性脑胶质瘤,随后行同期放化疗:多中心经验。
Neurosurg Rev. 2010 Oct;33(4):441-9. doi: 10.1007/s10143-010-0280-7. Epub 2010 Aug 13.
10
Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients.老年原发性多形性胶质母细胞瘤术后放疗联合替莫唑胺治疗
Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):987-92. doi: 10.1016/j.ijrobp.2007.07.2368. Epub 2007 Oct 29.

引用本文的文献

1
Application of three-dimensional cell culture technology in screening anticancer drugs.三维细胞培养技术在抗癌药物筛选中的应用。
Biotechnol Lett. 2023 Sep;45(9):1073-1092. doi: 10.1007/s10529-023-03410-x. Epub 2023 Jul 8.
2
Characterization and prognosis of temozolomide-induced aplastic anemia in patients with central nervous system malignancies.替莫唑胺致中枢神经系统恶性肿瘤患者再生障碍性贫血的特征及预后。
Neuro Oncol. 2022 Jun 1;24(6):964-973. doi: 10.1093/neuonc/noab240.
3
Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review.

本文引用的文献

1
The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models.肿瘤体积在胶质母细胞瘤患者预后中的重要性:计算机体积测量法与几何模型的比较
Strahlenther Onkol. 2009 Nov;185(11):743-50. doi: 10.1007/s00066-009-2015-7. Epub 2009 Nov 10.
2
A rare case of aplastic anemia caused by temozolomide.一例由替莫唑胺引起的罕见再生障碍性贫血病例。
South Med J. 2009 Sep;102(9):974-6. doi: 10.1097/SMJ.0b013e3181b1d2fa.
3
Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas.
致命性替莫唑胺诱发多形性胶质母细胞瘤女性患者再生障碍性贫血:一例报告及文献综述
Clin Case Rep. 2021 Jan 28;9(3):1641-1646. doi: 10.1002/ccr3.3860. eCollection 2021 Mar.
4
Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide.替莫唑胺治疗间变性星形细胞瘤期间发生再生障碍性贫血
Case Rep Oncol. 2020 Oct 13;13(3):1244-1251. doi: 10.1159/000509744. eCollection 2020 Sep-Dec.
5
The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment.氯尼达明联合化疗和物理治疗在癌症治疗中的潜力
Cancers (Basel). 2020 Nov 11;12(11):3332. doi: 10.3390/cancers12113332.
6
Temozolomide-induced aplastic anaemia and incidental low-grade B-cell non-Hodgkin lymphoma in a geriatric patient with glioblastoma multiforme.替莫唑胺诱发的老年多形性胶质母细胞瘤患者再生障碍性贫血及偶然发现的低级别B细胞非霍奇金淋巴瘤
BMJ Case Rep. 2019 Jun 29;12(6):e228803. doi: 10.1136/bcr-2018-228803.
7
Temozolomide-induced Aplastic Anemia Treated with Eltrombopag and Granulocyte Colony Stimulating Factor: A Report of a Rare Complication.用艾曲泊帕和粒细胞集落刺激因子治疗替莫唑胺引起的再生障碍性贫血:一例罕见并发症报告
Cureus. 2018 Sep 18;10(9):e3329. doi: 10.7759/cureus.3329.
8
Adjuvant temozolomide-based chemoradiotherapy versus radiotherapy alone in patients with WHO III astrocytoma: The Mainz experience.对于世界卫生组织III级星形细胞瘤患者,辅助替莫唑胺化疗联合放疗与单纯放疗的比较:美因茨经验。
Strahlenther Onkol. 2015 Aug;191(8):665-71. doi: 10.1007/s00066-015-0855-x. Epub 2015 May 30.
9
Temozolomide-induced liver damage. A case report.替莫唑胺引起的肝损伤。病例报告。
Strahlenther Onkol. 2014 Apr;190(4):408-10. doi: 10.1007/s00066-013-0519-7. Epub 2014 Jan 24.
10
Radiotherapy with and without temozolomide in elderly patients with glioblastoma.替莫唑胺放化疗与单纯放疗治疗老年胶质母细胞瘤患者的疗效比较。
Strahlenther Onkol. 2012 Feb;188(2):154-9. doi: 10.1007/s00066-011-0026-7. Epub 2012 Jan 11.
围手术期高剂量率近距离放射治疗复发性恶性胶质瘤
Strahlenther Onkol. 2009 Aug;185(8):524-9. doi: 10.1007/s00066-009-1965-0. Epub 2009 Aug 4.
4
Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice.替莫唑胺治疗原发性多形性胶质母细胞瘤的疗效在常规临床实践中的应用。
J Neurooncol. 2010 Jan;96(2):249-57. doi: 10.1007/s11060-009-9956-7. Epub 2009 Jul 7.
5
Temozolomide in malignant gliomas: current use and future targets.替莫唑胺在恶性胶质瘤中的应用:当前使用情况及未来靶点
Cancer Chemother Pharmacol. 2009 Sep;64(4):647-55. doi: 10.1007/s00280-009-1050-5. Epub 2009 Jun 19.
6
Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?复发性胶质母细胞瘤的低分割立体定向再照射:高剂量放疗后的一种有益治疗选择?
Strahlenther Onkol. 2009 Apr;185(4):235-40. doi: 10.1007/s00066-009-1753-x. Epub 2009 Apr 16.
7
Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma.胶质母细胞瘤术后放疗联合同步替莫唑胺且不进行辅助化疗的随机研究
Strahlenther Onkol. 2008 Nov;184(11):572-9. doi: 10.1007/s00066-008-1897-0. Epub 2008 Nov 19.
8
Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature.低剂量替莫唑胺治疗后两名患者出现长期严重骨髓抑制——病例研究及文献综述
J Neurooncol. 2007 Nov;85(2):229-30. doi: 10.1007/s11060-007-9403-6. Epub 2007 May 26.
9
The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas.替莫唑胺和放疗所致血小板减少对新诊断的成年高级别胶质瘤患者的影响。
Neuro Oncol. 2007 Jan;9(1):47-52. doi: 10.1215/15228517-2006-024. Epub 2006 Nov 15.
10
Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide.多形性胶质母细胞瘤患者接受替莫唑胺治疗后发生再生障碍性贫血。
Lancet Oncol. 2006 May;7(5):436-8. doi: 10.1016/S1470-2045(06)70696-9.